WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ: TLRY) in connection with the Company’s proposed merger with Aphria Inc. (“Aphria”) (NASDAQ: APHA), a global cannabis growth and production company. Under the terms of the merger agreement, Aphria shareholders will receive 0.8381 shares of Tilray for each Aphria share they own. The post-close combined company will trade on the NASDAQ under the symbol “TLRY.” Upon closing of the proposed transaction, former Aphria shareholders will own a majority of the combined company with Tilray shareholders only owning approximately 38% of the combined company. The post-transaction combined company has an implied pro forma equity value of approximately $3.9 billion.
If you own Tilray shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website: